Interviews with Key Healthcare Opinion Leaders - Episode #91
Jan 10 2025
Length: 1 hr and 1 min
Podcast

Failed to add items

Sorry, we are unable to add the item because your shopping cart is already at capacity.

Add to Cart failed.

Please try again later

Add to Wish List failed.

Please try again later

Remove from wishlist failed.

Please try again later

Adding to library failed

Please try again

Follow podcast failed

Please try again

Unfollow podcast failed

Please try again

Interviews with Key Healthcare Opinion Leaders - Episode #91

Listen for free

View show details

Summary
Julie Schulz, MD, MPH, Physician Executive, Product leader, and VP of Product, and Michael Dovidio, PharmD, Product Manager at Avalon Healthcare Solutions, discuss why leveraging cardiometabolic lab values instead of BMI to determine coverage for GLP-1 drugs would improve prescription availability for diabetic and obese patients.
Hosted on Acast. See acast.com/privacy for more information.

Show more Show less

Limted time offer. Just $0.99 a month for the first 3 months. Get this deal.

Show more Show less

What listeners say about Interviews with Key Healthcare Opinion Leaders - Episode #91

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews

No Reviews are Available

Report a review on Amazon